Lumiere Health International, Inc. provides consulting services for victims of human rights violations or crimes against humanity.This includes social inequity, civil rights, war crimes, and torture—both domestically and internationally.
We serve the world’s most vulnerable communities, helping forced migrants and refugees who’ve experienced conflict and persecution. These individuals include unaccompanied minors, asylum seekers, and victims of civil violations abuses in the United States. We also offer consultations to international organizations and policy recommendations at the local, state, and federal level.
We are purpose-driven organization. Our core mission is to illuminate challenges and champion and enable opportunities for forced migrants, asylum seekers, refugees, and other minority groups. For us, that means doing our best to eradicate social inequities—offering equal legal representation and closing healthcare disparity gaps.
As part of Lumiere you will assume an instrumental role in developing solutions with long-lasting impact for the organization, our mission, and patients. You will join a passionate team of seasoned professionals dedicated to advancing human rights by addressing root-causes and closing the gaps that contribute to social inequality, injustice, and long-term chronic diseases. ... Read more about 370. Lumiere Health International, San Francisco and New York City
What is Personalized Care? Personalized Care will benefit up to 2.5 million people by 2024, giving them the same choice and control over their mental and physical health that they have come to expect in every other aspect of their life. A one-size-fits-all health and care system simply cannot meet the increasing complexity of people’s needs and expectations. Personalised care is based on ‘what matters’ to people and their individual strengths and needs. But you may wonder – what exactly do we mean by ‘Personalized Care?’ Watch this short explanatory video taking you through the...
The Computational Epidemiology Lab Harvard Medical School leverages Machine learning and Artificial Intelligence systems to track and predict disease outbreaks using innovative digital platforms for digital surveillance and prevention. Our overall goal is to show how emerging technologies can help clarify patterns of disease and promote public health. Our mission has materialized in a diverse set of projects that include describing the emergence of West Nile virus in New York City using satellite data, predicting patterns of Lyme disease based on climate change, analyzing patterns of influenza epidemics, finding new ways to identify problem medications using electronic medical records, understanding the geographic patterns of substance abuse, describing the impact of pollution on chronic disease, and most recently the first documented use of mobile smartphones as public health surveillance tools for both outbreak and post-marketing surveillance.
We’re looking for a driven, creative thinker to help us assess and accelerate digital health innovation projects in the Computational Epidemiology Lab. A successful applicant has a background in data science, machine learning, healthcare or technology and is passionate about translating data into information that can impact real-world decisions. In this role, you’ll be paired with a mentor that is an expert in epidemiology data analytics, innovation and will work on projects that seek to use unconventional big data to understand human behaviors and population health.... Read more about 366. Computational Epidemiology Lab at Harvard Medical School, Boston MA
The Global Health Institute (GHI) at the American University of Beirut (AUB) was formally established in July 2017. As the first such institute in the Middle East and North Africa region, GHI aims to address global health challenges with a focus on context and sustainable impact by employing an interdisciplinary approach. The primary focus of GHI are challenges that are affecting the MENA region, but have relevance to and impact on other regions in the Global South.... Read more about 363. American University of Beirut Global Health Institute, Beirut, Lebanon
Wadhwani Institute for Artificial Intelligence (Wadhwani AI) is an independent, nonprofit applied research institute and global hub developing AI solutions for social good. Our mission is to apply the power of artificial intelligence to solve the world’s toughest problems in domains such as health, agriculture, financial inclusion, education, and smart cities. Our team consists of world-renowned scientists, innovators, and entrepreneurs from Microsoft, Stanford, Yale, Cornell, and IITs. In addition to our in-house capabilities, we work closely with...
SaveLIFE Foundation (SLF) is an independent, non-profit organization committed to improving road safety and access to emergency medical care across India and the developing world.
SLF connects research, advocacy, communication and execution (RACE) to operate at the intersection of policy making and grassroots implementation for crash prevention as well as post-crash response. Over the past few years, SLF has facilitated the enactment of key legislations in India such as the Good
Samaritan Law adopted one of India’s deadliest highways to transform it into a Zero fatality corridor, trained thousands of Police officers and volunteers in life-saving techniques and built award-winning technology to connect and assist stakeholders including bereaved families from extremely poor backgrounds.
The Reconstruction and Mechanics of the Middle Ear lab under Aaron Remenschneider, MD, MPH at Massachusetts Eye and Ear in downtown Boston studies a variety of pathologies and novel engineering solutions to problems faced in the middle ear, particularly with respect to the tympanic membrane (eardrum). The tympanic membrane is a thin tissue that captures sound waves from the environment and transmits them to the ossicles (bones) of the middle ear. Current projects in the lab include 3D printing of novel biodegradable grafts for tympanic membrane repair, investigating tympanic membrane remodeling in chinchilla models and human histopathological samples, and studying the acoustics of the middle ear following various reconstruction procedures. We also use human temporal bone specimens to improve our understanding of the mechanics of the middle ear and the impact of novel devices on hearing.
Age- and noise-related hearing loss present a major global health challenge worldwide. Specifically, over 5% of the population has disabling hearing loss, affecting approximately 466 million people worldwide each year. Current hearing aids seek to increase the sound pressure level that reaches the tympanic membrane, or eardrum, via amplification of sound waves in an electronic microphone-to-speaker system. Unfortunately, these hearing aids present challenges with maintenance, battery life, and environmental usage restrictions. Thus, patient adherence can be low for these devices. Our team seeks to create a passive hearing aid device utilizing novel materials and 3D printing techniques to augment the structure of the tympanic membrane. We hypothesize that by augmenting the circular/radial structure of the tympanic membrane, which has been shown to be important for enabling sound conduction at both low and high frequencies, we may be able to enhance the sound-induced motion of the tympanic membrane to sound waves. In this way, we may be able to develop a fully implantable device that enhances the motion of the ossicles and therefore cochlear fluid to improve hearing. Such an implantable device would negate the need for electronic components, batteries, routine maintenance, and water precautions.... Read more about 113. Reconstruction and Mechanics of the Middle Ear Lab, Massachusetts Eye & Ear, Boston, MA
Did you know there are around 19 million new cancer patients every year? A study called “World Cancer Report 2018” released by the International Agency for Research on Cancer (IARC) showed recently that the cancer burden has risen from 14 million to 18.1 million new cases and around 9.6 million people died because of it in 2018 alone. OMS’s projections for 2030 are not any better. 29.5 million new cases and 16.3 million deaths on a year basis. Its treatment is long and full of challenges. High patient / doctor ratio, long time period between doctor appointments and the ‘poor memory'...
Gavi is an international organisation that was created in 2000 to improve access to new and underused vaccines for children living in the world’s poorest countries. Based in Geneva, Switzerland, Gavi is the Vaccine Alliance, which brings together public and private sectors with the shared goal of creating equal access to vaccines for children, wherever they live. ... Read more about 336. Gavi, Geneva, Switzerland
Please Note: This internship is co-sponsored with The Center for Public Service & Engaged Scholarship’s Mindich Summer Service Fellowship. The primary affiliation is with HGHI, so HGHI will be the point of contact during the application and internship onboarding process. The intern selected for this internship will have the obligations and benefits of an intern in both HGHI and The Center for Public Service & Engaged Scholarship.
You must be a rising senior to apply.
UNFPA is the lead United Nations sexual and reproductive health and rights (SRHR) agency. Our mission is to deliver a world where every pregnancy is wanted, every childbirth is safe and every young person's potential is fulfilled. UNFPA is formally named the United Nations Population Fund. The organization was created in 1969, the same year the United Nations General Assembly declared “parents have the exclusive right to determine freely and responsibly the number and spacing of their children.” UNFPA’s current strategic plan (2018-2021), focuses on three transformative results: to end preventable maternal deaths; end unmet need for family planning; and end gender-based violence and harmful practices.... Read more about 332 United Nations Population Fund (UNFPA), New York City, NY
The Division of International Epidemiology and Population Studies (DIEPS) is the research arm of the Fogarty International Center. Located on the NIH campus in Bethesda, MD, DIEPS conducts research in epidemiology, genomics, and mathematical modeling of infectious diseases. Primary concentrations include cross-national studies of transmission dynamics, mortality patterns, phylodynamics, with special emphasis on SARS-CoV-2, influenza and other respiratory viral diseases. Other projects include clean cooking implementation science to reduce household air pollution and biosafety and biosecurity training in LMICs. Outcomes of DIEPS research and other activities include changes in public health policies and practices to decrease disease burdens. ... Read more about 330. NIH Fogarty International Center, Bethesda, MD
Perinatal HIV Research Unit (PHRU) is one of Africa’s leading research centres, situated at the Chris Hani Baragwanath Hospital—known locally as ‘Bara’—in Soweto, Johannesburg. PHRU is affiliated with the University of the Witwatersrand and engages in research, training, policy-formulation and advocacy concerning HIV-positive and -negative people and their children.
Specifically, PHRU conducts adult, paediatric and adolescent HIV treatment research, HIV prevention research and investigations into tuberculosis and other HIV co-infections. In addition to the numerous pharmaceutical and publicly-funded clinical trials, the unit also conducts important behavioural and social science research, advocates for research access and provides needed care to the people of Soweto.
NICE (The National Institute for Health and Care Excellence) is public body in the United Kingdom, whose purpose is to improve health and wellbeing by putting science and evidence at the heart of health and care decision making. Our work spans three main ecosystems:
Guidelines – developing best practice recommendations and advice for front-line practitioners
Regulatory – evaluating health technologies to determine funding decisions and new procedures to assess safety
Information – providing evidence-based information and advice, such as the British National Formulary and Clinical Knowledge Summaries
This is an exciting moment in NICE’s history – we are developing a new 5-year strategy, due to be launched in April 2021. The strategy will reflect our ambition to deliver ‘living’ guidelines and innovative evaluation methodologies that incorporate new forms of data and real-world evidence, to improve health and care outcomes.
Please Note: This internship is co-sponsored with the IOP's Director's Internship Program. The primary affiliation is with HGHI, so HGHI will be the point of contact during the application and internship onboarding process. The intern selected for this internship will have the obligations and benefits of an intern in both programs.The IOP has a strict two-application limit for opportunities they fund, which includes internships that are co-sponsored with HGHI.
NHS England and NHS Improvement lead the National Health Service (NHS) in England, setting the priorities and direction of the NHS and informing the national debate to improve health and care.
As organisations, we share out more than £100 billion in funds and hold organisations to account for spending this money effectively for patients and efficiently for the tax payer. We also directly commission certain services such as primary care and ‘specialised services’, such as treatments for rare conditions and secure mental health care, on a regional or national basis.
We work closely with central government including the Department of Health and Social Care, Department for Work and Pensions, the Office for Life Sciences and others. We also have a good relationship with national bodies responsible for the regulation of health and care, health research and local government.
Officially established in February 2009 at MGH, MIT and Harvard, The Phillip T. and Susan M. Ragon Institute has the dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently to establish itself as a world leader in the collaborative study of immunology.
Dr. Alter is PI of the largest lab at the Ragon Institute. Dr. Alter’s research interests lie at the intersection of the innate immune response and the adaptive humoral immune response, with a focus on defining the role of innate immune recruiting antibodies in providing specificity to the innate immune system to kill virally infected cells. In this capacity, Dr. Alter has developed a suite of antibody profiling assays that aim at gaining a deeper appreciation of the correlates of humoral immune activity against HIV and beyond.... Read more about 112. The Alter Lab at the Ragon Institute of MGH, MIT, and Harvard, Boston, MA